BioTech 365

SEPTEMBER 29, 2021

Avacta Group plc: Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership Avacta Group plc: Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership CAMBRIDGE & WETHERBY, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), a clinical stage … Continue reading → (..)

Life Science 52

Life Science Clinical Development Development 52

XTalks

APRIL 14, 2021

FDA-mandated clinical holds, strategic partnership breakups and $800 million biotech acquisitions. She shares how well the firms have weathered the COVID-19 pandemic, and the team discusses the outlook for the drug development industry in general. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 98

Life Science Gene Therapy Development Drugs 98

Pharmaceutical Technology

OCTOBER 28, 2022

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Robots can improve drug discovery and development.

Development 311

Development Drugs Pharma Companies Life Science 311

Outsourcing Pharma

AUGUST 22, 2023

Those in the life sciences industry needing some creative input can now turn to Bios Health Group who have recently launched into the space.

Life Science 86

Life Science Clinical Development Development 86

Pharmaceutical Technology

MAY 24, 2023

Forge Biologics has joined the public-private collaboration, the Bespoke Gene Therapy Consortium (BGTC), to expedite the development and manufacture of new AAV [adeno-associated virus] gene therapies to treat patients with rare diseases. Shilling was appointed to represent the company on the steering committee of the BGTC.

Gene Therapy 242

Gene Therapy Gene Development Manufacturing 242

pharmaphorum

MARCH 8, 2022

How did you get into life sciences? After a few years, I decided I wanted to move into the commercial side of the business, so I completed an MBA and went on to hold various positions in Corporate Business Development, Life Science and Healthcare. What has your career path been?

Life Science 98

Life Science Engineer Scientist Doctors 98

XTalks

NOVEMBER 15, 2023

This episode features an interview with Dr. Lahar Mehta, Head of Global Clinical Development at Amylyx Pharmaceuticals, who spoke to Xtalks about Amylyx’s clinical trial design of ORION, a Phase III Global Study of AMX0035 (Relyvrio) in Progressive Supranuclear Palsy (PSP).

Life Science 52

Life Science Trials Clinical Trials Clinical Trials 52

XTalks

DECEMBER 13, 2023

This episode features an interview with vaccine scientists and executives from Vaccines Global Clinical Development at Merck, Dr. Heather Platt, MD, Distinguished Scientist and Pneumococcal Vaccine Lead; and Dr. Ulrike Buchwald, MD, Scientific Associate Vice President, Global Clinical Research and Pneumococcal Vaccine Section Head.

Life Science 52

Life Science Vaccination Vaccine Scientist 52

pharmaphorum

JANUARY 5, 2024

Beckley Psytech has announced that is has received substantial strategic investment from atai Life Sciences, totalling $50 million, to accelerate the clinical development of short-duration psychedelics.

Life Science 97

Life Science Clinical Development Development 97

BioTech 365

MAY 12, 2021

Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates KZR-616 clinical development in three severe autoimmune diseases is advancing with several data readouts expected in … Continue reading →

Life Science 40

Life Science Clinical Development Development 40

BioTech 365

MARCH 11, 2021

Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates KZR-616 clinical development in three severe autoimmune diseases … Continue reading →

Life Science 52

Life Science Clinical Development Development 52

XTalks

JANUARY 5, 2021

The pandemic itself will also continue to spur innovations and changes such as greater shifts towards decentralized clinical trials and patient-centric approaches. In addition to vaccines, there are handfuls of drugs currently being evaluated in clinical trials for the treatment of COVID-19. 1. COVID-19 Pandemic: An Evolving Era.

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

The Pharma Data

MARCH 15, 2022

Investment will accelerate the overall Sarclisa ® development program Sanofi will continue to fully manage the clinical program and retain full rights and control of Sarclisa ® (isatuximab). to advance the development of a subcutaneous delivery for Sarclisa ® with the goal of offering a unique patient-centric treatment experience.

Life Science 52

Life Science Antibody Clinical Trials Clinical Trials 52

Pharmaceutical Technology

JUNE 6, 2023

Led by Bain Capital Life Sciences, the financing round has also seen participation from Sofinnova Investments, TCGX and Wellington Management. Gildeuretinol is the first and only medicine in clinical development to treat Stargardt disease by reducing vitamin A dimerization in the eye, without affecting normal vision.

Genetics 279

Genetics Life Science Trials Clinical Development 279

Pharmaceutical Technology

APRIL 12, 2023

Cognizant and Boehringer Ingelheim are collaborating on an integrated cloud platform to enhance the speed and quality of medicinal therapy development. Cognizant will leverage the Veeva Development Cloud platform to help Boehringer Ingelheim to merge medicinal development processes and data into a connected technology ecosystem.

Medicine 130

Medicine Life Science Development Branding 130

The Pharma Data

NOVEMBER 30, 2020

Shailubhai will provide updates on the Company’s proposed move from AIM to the Standard Segment of the Main Market of the London Stock Exchange, ongoing clinical trials, as well as other recent developments in Tiziana Life Sciences. About Tiziana Life Sciences. NEW YORK and LONDON, Dec.

Life Science 40

Life Science Antibody Clinical Trials Clinical Trials 40

Drug Discovery World

FEBRUARY 28, 2024

Lu Rahman selects some of the year’s interesting and noteworthy advances in cancer research drug discovery and development. As always, a year within cancer drug discovery and development brings with it significant breakthroughs, and 2023 has been no exception. Figures from the Amercian Cancer Society 1 state that “a little over 1.9

Development 62

Development Research Drugs Antibody 62

Outsourcing Pharma

APRIL 15, 2024

Michael Fronstin, global head of client partnership and commercialization at the company said the combination of Oracleâs life sciences expertise and platform technology help CROs win more business and run trials more efficiently.

Life Science 97

Life Science Trials Clinical Development Development 97

XTalks

OCTOBER 4, 2023

How do you make strategic decisions around products that are in the early stage of development and are still years from regulatory approval and launch? In the specialized, personalized and advanced medicines spaces, this work should start very early — as early as Phase I or Phase II of clinical development.

Marketing 105

Marketing Development Drugs Gene Therapy 105

pharmaphorum

MARCH 17, 2021

Charity-funded medical research is a vital cog in the clinical development machine – but COVID-19 has left it facing an existential threat. It means groups have had to take difficult decisions around research funding – decisions that could have long-term reverberations for the whole clinical development sector. “We

Research 98

Research Development Life Science Clinical Development 98

Pharmaceutical Technology

AUGUST 9, 2022

In the clinical development programme, 1,944 epilepsy patients received cenobamate treatment. Discovered by SK Biopharmaceuticals and SK life science, cenobamate is a new small molecule anti-seizure therapy.

Life Science 246

Life Science Clinical Development Trials Marketing 246

Outsourcing Pharma

MARCH 9, 2021

The development technology firm plans to use the funds, sourced from a wide range of investors, to expand its dev-ops platform and expand its global reach.

Life Science 73

Life Science Development Clinical Development 73

The Pharma Data

JANUARY 14, 2021

I am pleased that we at Awakn are spear-heading the global initiative to develop new efficacious strategies for tackling this condition. ” About Awakn Life Sciences. Our patients deserve the best that cutting-edge psychopharmacology research can offer.” ” The study team is chaired by Prof.

Life Science 52

Life Science Clinical Trials Clinical Trials Trials 52

Outsourcing Pharma

MARCH 1, 2024

a prominent figure in metabolomics solutions, has launched a seminal integrated bioinformatics platform, aiming to redefine metabolomics analysis in life sciences research. Metabolon, Inc.,

Bioinformatics 87

Bioinformatics Life Science Research Clinical Development 87

pharmaphorum

NOVEMBER 12, 2020

Swiss startup Synendos Therapeutics has raised CHF 20 million (almost $22 million) in first-round financing that will be used to develop its endocannabinoid drugs for central nervous system disorders. Synendos says the cash will allow it to take its lead product SYT-510 through preclinical and proof-of-concept clinical development.

Development 106

Development Drugs Life Science Clinical Development 106

The Pharma Data

SEPTEMBER 29, 2021

The new FIND-CKD study extends our clinical research for finerenone to a non-diabetic population where the unmet need is high for brand spanking new treatments to delay disease progression.”. About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition.

Clinical Development 52

Clinical Development Development Clinical Trials Clinical Trials 52

XTalks

JANUARY 23, 2024

Among these, rare pediatric diseases present unique challenges and opportunities for rare disease drug development. Pediatric growth hormone deficiency (PGHD) is one such condition, affecting a child’s growth and development. This venture also led me to identify a gap in the market for contract manufacturing of recombinant proteins.

Development 72

Development Hormones Drugs Trials 72

Outsourcing Pharma

JANUARY 24, 2024

Elisa Cascade is chief product officer at Advarra, a business that says it aims to advance the way clinical research is conducted by bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration.

Life Science 100

Life Science Clinical Research Production Research 100

Drug Discovery World

MARCH 14, 2023

Teitur Trophics, a biotech company developing new treatments for patients suffering from neurodegenerative diseases, has complete a €28M Series A financing. The financing was co-led by Sunstone Life Science Ventures and Sound Bioventures, with participation from new investors, Industrifonden, Innovestor’s Life Science Fund and P53 Invest.

Life Science 52

Life Science Clinical Development Development Drugs 52

pharmaphorum

MAY 20, 2021

Switzerland’s Numab has raised 100 million Swiss francs – around $110 million – in Series C financing to develop bispecific antibodies for cancer and inflammation, with Novo Noldings and HBM Partners co-leading the investor syndicate. The post Numab raises $110m to develop cancer bispecific antibodies appeared first on.

Antibody 52

Antibody Development Clinical Development Life Science 52

Drug Discovery World

MAY 6, 2024

Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. This article takes a closer look at several key clusters in the region.

Drugs 57

Drugs Life Science Gene Editing Gene 57

Drug Discovery World

FEBRUARY 12, 2024

Cameron Ross, SVP, Generative AI, Elsevier “AI has the potential to dramatically shorten one of the most costly areas of early drug development – small molecule discovery. The emergence of low-code and no-code software engineering will start to make CGT application development easier, enabling more rapid, innovative solutions.

Genome 139

Genome Genomics Life Science Gene Therapy 139

XTalks

OCTOBER 7, 2020

However, these complex treatments present challenges to developers over and above the well-documented hurdles of rare-disease research. The Xtalks White Paper, The Intersection of Rare Disease and Advanced Therapies: What it Means for Clinical Development , is available for free download. Adjusting for COVID-19.

Development 98

Development Gene Therapy Clinical Trials Clinical Trials 98

The Pharma Data

JANUARY 26, 2021

27, 2021 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announces that it has filed a “universal” shelf registration statement on Form F-3 (File No. About Tiziana Life Sciences.

Life Science 40

Life Science Sales Antibody Marketing 40

Outsourcing Pharma

OCTOBER 20, 2023

He has been reflecting on his time at DPharm and the collaborative approach to life sciences. Dave Hine is the senior director of sales and engineering at Greenphire.

Life Science 90

Life Science Engineer Sales Clinical Development 90

The Pharma Data

FEBRUARY 24, 2022

Up to 40% of all patients with type 2 diabetes (T2D) develop CKD. The cardiology franchise at Bayer already includes a number of products and several other compounds in various stages of preclinical and clinical development. Bayer is committed to drive sustainable development and generate a positive impact with its businesses.

Clinical Development 52

Clinical Development Development Cardiology Life Science 52

pharmaphorum

APRIL 19, 2021

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . If you look at the development, we signed 15,000 people in six weeks in a trial set up by the NHS.

Vaccination 141

Vaccination Vaccine Manufacturing Clinical Development 141